Occurrence of IMP-1 in non-baumannii Acinetobacter clinical isolates from Brazil.
暂无分享,去创建一个
L. Dijkshoorn | A. Gales | R. Cayô | A. Pignatari | A. Matos | A. P. Streling | C. Nodari | Adryella de Paula Luz
[1] A. Gales,et al. Identification of a New Integron Harboring blaIMP-10 in Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates , 2015, Antimicrobial Agents and Chemotherapy.
[2] K. Ko,et al. Acinetobacter species isolates from a range of environments: species survey and observations of antimicrobial resistance. , 2012, Diagnostic microbiology and infectious disease.
[3] K. Ko,et al. Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea. , 2012, International journal of antimicrobial agents.
[4] D. Raoult,et al. Validation of partial rpoB gene sequence analysis for the identification of clinically important and emerging Acinetobacter species. , 2009, Microbiology.
[5] M. Castanheira,et al. Dissemination of bla(IMP-1)-carrying integron In86 among Klebsiella pneumoniae isolates harboring a new trimethoprim resistance gene dfr23. , 2009, Diagnostic microbiology and infectious disease.
[6] A. Gales,et al. Dissemination of IMP-1 Metallo-β-Lactamase–Producing Acinetobacter Species in a Brazilian Teaching Hospital , 2006, Infection Control & Hospital Epidemiology.